Description

• General description: This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG
• Application: Antidepressant potential of triterpenoids: Madecassic acid, identified as a key triterpenoid in Centella asiatica, is explored for its antidepressant properties through in vivo and computational studies, underscoring its potential role in neuropsychiatric disorder treatments (Mando et al., 2024).Cardiotoxicity assessment: Research indicates that madecassic acid can induce cardiotoxicity by promoting inflammation and generating excessive reactive oxygen species, highlighting critical safety concerns in its pharmacological use (Guo et al., 2024).Neuroprotective effects in cognitive decline: A study demonstrates that Centella asiatica, containing madecassic acid, enhances memory and executive functions in aging rats, suggesting its therapeutic efficacy against age-related cognitive disorders (Firdaus et al., 2024).Anti-angiogenic properties: Madecassic acid is investigated for its role in inhibiting angiogenesis, with network pharmacology and experimental validation pointing to potential applications in cancer treatment strategies (Zhao et al., 2024).Antioxidative and anti-inflammatory effects: This compound from Centella asiatica extract is shown to exert antioxidative and anti-neuroinflammatory effects, particularly beneficial in neurodegenerative diseases like Alzheimer′s (Hambali et al., 2024).
• Legal Information: phyproof is a registered trademark of PhytoLab GmbH & Co. KG